Preparing for a Post-PAMA Marketplace:
Market Based Payment for Clinical Diagnostic Laboratory Tests Starting in 2018

[el-text]

Section 216 of PAMA significantly changes the way in which diagnostics are coded and paid on the CLFS. Such changes require a strong knowledge base of commercial payment processes and key relationships with payers that heretofore is not common among many companies. ADVI has a comprehensive understanding of the issues and has worked closely with key architects of the legislation as well as those crafting solutions to it, resulting in customized strategies for our clients. We maintain deep relationships with payers, which can be leveraged to glean important insight from key decision-makers.

[/el-text]

[el-text]

Download full analysis here

[/el-text]